About Us
HekaBio is a unique platform for healthcare innovation in Japan,
created by a diverse group of multicultural experts
We invest in leading global innovations in oncology, radiation and cardiovascular therapy, and successfully accelerate commercialization
Our mission is to bring significant benefit to patients suffering from intractable diseases
Name
HekaBio K.K.
Head Office
1-9-15 Nihonbashimuromachi, Chuo-ku, Tokyo 103-0022
Establishment
November 14, 2016
Representative
Robert E. Claar
Meaning of "Heka"
In Egyptian mythology, Heka is the personification of healing and magic. Heka literally means “engaging the spirit or vital force”.
Credit of photo: Esna_Tempel_13.jpg:
Olaf Tausch derivative work: Oltau, CC BY 3.0, via Wikimedia Commons
Meet The Team
Rob Claar
Co-founder, CEO
Rob creates new businesses that address the unmet needs of patients, doctors, innovators and authorities. He is passionate about developing creative solutions for access to Japan’s healthcare market.
Over three decades, Rob has founded, managed and exited a number of businesses including Junicon, a global healthcare marketing research consultancy, and Vorpal Technologies, a MedTech regulatory consultancy.
He maintains a worldwide trust network with leading innovators in MedTech and pharma through optimism, tenacious follow-through and a spirit of collaboration.
Ben Pratt
Co-founder, COO
Ben has two decades of experience in healthcare strategy development, marketing, and operations. He commercialized and marketed best-in-class medical products globally and in Japan while at Edwards Lifesciences.
As GM at Vorpal Technologies, he consulted for global healthcare innovators and launched Vorpal Women’s Health, a commercial entity sold in 2017.
His forte and personal mission is creating new businesses for the betterment of patient care. Ben holds an MBA from the University of Southern California.
Hitoshi Torii
CFO
Hitoshi has 30 years of leadership experience in the life science industry including both large and venture biotech and pharmaceutical companies in executive management, finance, business development, and commercial roles.
Hitoshi’s background as a research scientist and financial professional make him a hands-on manager in biotech startups.
He is experienced in private equity fundraising and IPO preparation and holds MBA & USCPA qualifications.
Anne Bille, MD, PhD, MPH
Medical Advisor
Anne is the former head of Medical Affairs, Clinical Development and Operations at Baxalta and Baxter Japan and was Medical Director for programs at Wyeth Japan and Eli Lilly Japan. Anne is a licenced Psychiatrist and has a track record of leading successful regulatory and clinical programs in oncology, CNS, hemophilia and anesthesia. Anne has been a resident of Japan for 19 years.
Our Core Values
Collaboration
We maintain internal and external relationships built on common goals,
mutual respect, open communication, trust and teamwork
Creativity
We approach situations with a positive attitude, acting on needs and
opportunities to deliver inspired solutions
Commitment
We are proactive self-starters who are accountable for results